Human HLA-C*04:01:01 cDNA from human EBV-transformed B cell line cDNA
|
Other clones in our bank
External Database Human HLA-Cw*04011 Reference sequence |
Sequence | RDB02886z.seq |
---|---|
Remarks, protocol and/or map (gif) | RDB02886.gif |
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Terms and conditions for distribution | In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of literature(s) designated by the DEPOSITOR is requested (Akatsuka et al., Tissue Antigens 59, 502-511 (2002).). |
---|---|
Ordering | Please visit Information of Request for Distribution.[link] For for-profit-research purpose, please contact us. Order form [Credit Card Payment] [Bank Transfer Payment] Material Transfer Agreement (MTA for use for not-for-profit academic purpose) [Word] |
提供条件 | 利用者は、研究成果の公表にあたって寄託者の指定する文献を引用する (Akatsuka et al., Tissue Antigens 59, 502-511 (2002).)。 |
---|---|
提供依頼 | 手続きの詳細は、「提供申込みについて[link]」をご覧ください。営利目的利用についてはお問い合わせください。 提供依頼書 [Word] 提供同意書 (MTA、非営利機関による非営利学術研究用)[Word] |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB02886 | Human HLA-C*04:01:01 cDNA | DNA solution |
Materials & Methods section:
The Human HLA-C*04:01:01 cDNA was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB02886). |
Reference section:
Further references such as user reports and related articles (go to bottom)
Featured content
Featured content | HLA Clones (en) (English text) |
---|---|
Featured content | HLA Clones (ja) (Japanese text) |
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB19178_B1Ftp1-1.pdf |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: CMV_Forward (Pr0016) Region: CMV pro, insert 5' Sequence file: RDB19178_B1Fta.seq |
---|
>02886_19178_B1Ft_3_CMV-Forward_F02_17_ABI24.ab1 1 NNNNNNNNNT NNNNNNNNNN GGGCGGTAGG CGTGTACGGT GGGAGGTCTA TATAAGCAGA 61 GCTCTCTGGC TAACTAGAGA ACCCACTGCT TACTGGCTTA TCGAAATTAA TACGACTCAC 121 TATAGGGAGA CCCAAGCTGG CTAGCGTTTA AACTTAAGCT TTTCTCCCCA GACGCCGAGA 181 TGCGGGTCAT GGCGCCCCGA ACCCTCATCC TGCTGCTCTC GGGAGCCCTG GCCCTGACCG 241 AGACCTGGGC CGGCTCCCAC TCCATGAGGT ATTTCTCCAC ATCCGTGTCC TGGCCCGGCC 301 GCGGGGAGCC CCGCTTCATC GCAGTGGGCT ACGTGGACGA CACGCAGTTC GTGCGGTTCG 361 ACAGCGACGC CGCGAGTCCA AGAGGGGAGC CGCGGGAGCC GTGGGTGGAG CAGGAGGGGC 421 CGGAGTATTG GGACCGGGAG ACACAGAAGT ACAAGCGCCA GGCACAGGCT GACCGAGTGA 481 ACCTGCGGAA ACTGCGCGGC TACTACAACC AGAGCGAGGA CGGGTCTCAC ACCCTCCAGA 541 GGATGTTTGG CTGCGACCTG NGGCCGGACG GGCGCCTCCT CCGCGGGTAT AACCAGTTCG 601 CCTACGACGG CAAGGANTAC ATCGCCCTGA ACGANGNTCT GCGCTCCTGG ACCGCCNCGN 661 ANACGGCGGC TCANATCACC CNNCGNNAGN GGGGANNNNG CCCGTNNNNN NNNNCNNNNG 721 NNNNNNCNNN NNNNNNN // |
Primer: bGH_rev3 (Pr0885) Region: bGH p(A), insert 3' Sequence file: RDB19178_B1Ftb.seq |
>02886_19178_B1Ft_3_bGH_rev3_G02_20_ABI24.ab1 1 NNNNNNNNNN NGNNNNNGGG CANCAACAGN TGGCTGGCAA CTAGAAGGCA CAGTCGAGGC 61 TGATCAGCGG GTTTAAACGG GCCCTCTAGA CTCGAGCGGC CGCGTCTCAG GCTTTACAAG 121 CGATGAGAGA CTCATCAGAG CCCTGGGCAC TGTTGCTGGA CGCAGCCTGA GAGCAGCTCC 181 CTCCTTTTCC ACCTGAGCTC TTCCTCCTAC ACATCACAAC AGCCACCATA GCTCCTAGGA 241 CAGCTAGGAC AGCCAGGACA GCCAGGCCAG CAACGATGCC CACGATGGGG ATGGTGGGCT 301 GGGAAGACGG CTTCCATCTC AGGGTGAGGG GCTCCGGCAG CCCCTCGTGC TGAACATGGC 361 ACGTGTATCT CTGCTCTTCT CCAGAAGGCA CCACCACAGC TGCCCACTTC TGGAAGGTTC 421 CATCTCCTGC TGGCCTGGTC TCCACAAGCT CGGTGTCCTG AGTTTGGTCC TCCCCATCCC 481 ACTGCCAGGT CAGTGTGATC TCCGCAGGGT AGAAGCCCAG GGCCCAGCAC CTCAGGGTGG 541 CCTCATGGTC AGAGACGGGA TGNTGGGTCA CGTGTGTCTT TGGGTGTTCC GCGCGCTGCA 601 GCGTCTCCTT CCCGTTCTCC AGGTATCTGC GGANCCACTC NACGCACGTG CCCTCCAGGT 661 ANGCTCTCCG CTGCTCCGCC TCACGGGCCG CCTCCCACTT GCGCTGGNNG ANNNNNNNCN 721 NNNNNNNNN // |
Primer: SV40pro_F (Pr0110) Region: NeoR Sequence file: RDB19178_B1Ftc.seq |
>02886_19178_B1Ft_3_SV40pro_F_H02_23_ABI24.ab1 1 NNNNNNNNNN NNNNNNNNNN NNGNNGCTTT TTTGGANGCC TAGGCTTTTG CAAAAAGCTC 61 CCGGGNNCTT GTATATCCAT TTTCGGATCT GATCAAGAGA CAGGATGAGG ATCGTTTCGC 121 ATGATTGAAC AAGATGGATT GCACGCAGGT TCTCCGGCCG CTTGGGTGGA GAGGCTATTC 181 GGCTATGACT GGGCACAACA GACAATCGGC TGCTCTGATG CCGCCGTGTT CCGGCTGTCA 241 GCGCAGGGGC GCCCGGTTCT TTTTGTCAAG ACCGACCTGT CCGGTGCCCT GAATGAACTG 301 CAGGACGAGG CAGCGCGGCT ATCGTGGCTG GCCACGACGG GCGTTCCTTG CGCAGCTGTG 361 CTCGACGTTG TCACTGAAGC GGGAAGGGAC TGGCTGCTAT TGGGCGAAGT GCCGGGGCAG 421 GATCTCCTGT CATCTCACCT TGCTCCTGCC GAGAAAGTAT CCATCATGGC TGATGCAATG 481 CGGCGGCTGC ATACGCTTGA TCCGGCTACC TGCCCATTCG ACCACCAAGC GAAACATCGC 541 ATCGAGCGAG CACGTACTCG GATGGAAGCC GGTCTTGTCG ATCAGGANGA TCTGGACGAA 601 GAGCATCANG GGCTCGCGCC AGCCGAACTG TTCGCCAGGC TCAAGGCGCG CATGCCCGAC 661 NGCNANGNNC TCGTCNTGAC CCNTGGCGAN GCCNGCTTGN CNAANNNCAN NNNGNAAAAT 721 GNNNNNNTTT NNNNNNNNNN // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
2023.05.02
GNP_filter3_RDBDEP_html_230501.pl